Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

ProCyte reports results from hair growth trial

April 7, 1997

Pharmadigm's PB-OO5 enters phase II as burn treatment

April 2, 1997

ICOS initiates phase I with monoclonal antibody

April 1, 1997

Antiinflammatory compounds disclosed by Tsumura

April 1, 1997

Name change for Connective Therapeutics; patient enrollment completed in pivotal interferon trial

March 25, 1997

Additional U.S. patent issued for Cariel

March 25, 1997

Phase III results reported on finasteride for male pattern hair loss

March 24, 1997

New antiinflammatory agent from Yakult Honsha

March 24, 1997

Savage introduces nonhalogenated corticosteroid

March 24, 1997

RCT patents compounds for acne and other skin infections

March 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...